Drug Shortage Report for TEVA-VALSARTAN/HCTZ
Report ID | 1226 |
Drug Identification Number | 02357046 |
Brand name | TEVA-VALSARTAN/HCTZ |
Common or Proper name | TEVA-VALSARTAN/HCTZ |
Company Name | TEVA CANADA LIMITED |
Market Status | MARKETED |
Active Ingredient(s) | HYDROCHLOROTHIAZIDE VALSARTAN |
Strength(s) | 25MG 320MG |
Dosage form(s) | TABLET |
Route of administration | ORAL |
Packaging size | 30 |
ATC code | C09DA |
ATC description | ANGIOTENSIN II ANTAGONISTS, COMBINATIONS |
Reason for shortage | Delay in shipping of the drug. |
Anticipated start date | |
Actual start date | 2017-02-01 |
Estimated end date | 2018-04-30 |
Actual end date | 2018-04-30 |
Shortage status | Resolved |
Updated date | 2018-05-11 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 30 NOVOPHARM COURT TORONTO, ONTARIO CANADA M1B 2K9 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v18 | 2018-05-11 | French | Compare |
v17 | 2018-05-11 | English | Compare |
v16 | 2018-03-13 | French | Compare |
v15 | 2018-03-13 | English | Compare |
v14 | 2017-12-15 | French | Compare |
v13 | 2017-12-15 | English | Compare |
v12 | 2017-10-10 | French | Compare |
v11 | 2017-10-10 | English | Compare |
v10 | 2017-05-23 | French | Compare |
v9 | 2017-05-23 | English | Compare |
v8 | 2017-05-08 | French | Compare |
v7 | 2017-05-08 | English | Compare |
v6 | 2017-04-25 | French | Compare |
v5 | 2017-04-25 | English | Compare |
v4 | 2017-04-03 | French | Compare |
v3 | 2017-04-03 | English | Compare |
v2 | 2017-03-13 | French | Compare |
v1 | 2017-03-13 | English | Compare |
Showing 1 to 18 of 18